Physicochemical Properties
| Molecular Formula | C11H22CLNO4 |
| Molecular Weight | 267.75 |
| Exact Mass | 267.124 |
| CAS # | 6920-31-6 |
| Related CAS # | Isobutyryl-L-carnitine;25518-49-4;Isobutyryl-L-carnitine-d3 chloride |
| PubChem CID | 71749537 |
| Appearance | White to off-white solid powder |
| LogP | 0.202 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 17 |
| Complexity | 255 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | CC(C)C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-] |
| InChi Key | FWUACOYFRJEMMP-SBSPUUFOSA-N |
| InChi Code | InChI=1S/C11H21NO4.ClH/c1-8(2)11(15)16-9(6-10(13)14)7-12(3,4)5;/h8-9H,6-7H2,1-5H3;1H/t9-;/m1./s1 |
| Chemical Name | [(2R)-3-carboxy-2-(2-methylpropanoyloxy)propyl]-trimethylazanium;chloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Metabonomic analysis of toxic action of long-term low-level exposure to acrylamide in rat serum. Hum Exp Toxicol. 2018 Dec; 37(12): 1282-1292. |
Solubility Data
| Solubility (In Vitro) |
H2O :~250 mg/mL (~933.71 mM) DMSO :~30 mg/mL (~112.04 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (7.77 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (7.77 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (7.77 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 100 mg/mL (373.48 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7348 mL | 18.6741 mL | 37.3483 mL | |
| 5 mM | 0.7470 mL | 3.7348 mL | 7.4697 mL | |
| 10 mM | 0.3735 mL | 1.8674 mL | 3.7348 mL |